Articles by Disease (Hepatocellular Cancer)

Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

Journal: Current Cancer Drug Targets
Volume: 14
Page: 659-670
Author(s): Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho

Na⁺/K⁺ ATPase Inhibitors in Cancer

Journal: Current Drug Targets
Volume: 15
Page: 988-1000
Author(s): Konstantinos Alevizopoulos, Theodora Calogeropoulou, Florian Lang and Christos Stournaras

Targeting miRNAs for Pancreatic Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 20
Page: 5279-5286
Author(s): Min Shi, DachengXie, Yong Gaod and Keping Xie

MicroRNA-Mediated Cancer Metastasis Regulation via Heterotypic Signals in the Microenvironment

Journal: Current Pharmaceutical Biotechnology
Volume: 15
Page: 455-458
Author(s): Haizhong Ma, Chunli Liang, Guangxue Wang, Sujuan Jia, Qian Zhao, Zhendong Xiang, Yuan Li, William C. Cho, Richard G. Pestell, Li Liang and Zuoren Yu

MicroRNAs and Cancer; an Overview

Journal: Current Pharmaceutical Biotechnology
Volume: 15
Page: 430-437
Author(s): Lutfi Tutar, Esen Tutar and Yusuf Tutar

Nanoparticulate Drug Delivery Systems for Treatment of Hepatocellular Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 10
Page: 22-33
Author(s): Shruti S. Shrikhande, Darshana S. Jain, Rajani B. Athawale and Amrita N. Bajaj

Nanoparticulate Drug Delivery System to Overcome the Limitations of Conventional Curcumin in the Treatment of Various Cancers: A Review

Journal: Drug Delivery Letters
Volume: 4
Page: 116-127
Author(s): Moorthi Chidambaram and Kathiresan Krishnasamy